Table 4. Measures for estimation of synergic effect between histology subtype and N stage for the risk of distant metastasis in DTC.
Histology subtype | N stage | M1 case (%) | Total case | Odds ratio (95% CI) | P value |
---|---|---|---|---|---|
PTC | 0 | 371 (0.5) | 69,343 | Reference | |
1 | 684 (3.3) | 20,750 | 3.801 (3.224–4.482) | <0.001* | |
FTC | 0 | 188 (3.5) | 5,350 | 5.685 (4.576–7.062) | <0.001* |
1 | 69 (32.4) | 213 | 33.495 (22.402–50.083) | <0.001* | |
RERI | 76.973 (50.238–103.708) | ||||
AP | 0.864 (0.823–0.905) | ||||
SI | 7.930 (5.833–10.780) |
Adjusted for age at diagnosis, sex, race, tumor size, extrathyroidal extension. *, represent the P value <0.05. DTC, differentiated thyroid cancer; PTC, papillary thyroid cancer; CI, confidence interval; FTC, follicular thyroid cancer; RERI, relative excess risk; AP, attributable proportion; SI, synergy index.